EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial
R V Moerman, S Arends, P M Meiners, E Brouwer, F K L Spijkervet, F G M Kroese, A Vissink, H Bootsma
Annals of the Rheumatic Diseases Feb 2014, 73 (2) 472-474; DOI: 10.1136/annrheumdis-2013-203736